Kier, a leading provider of healthcare facilities in the UK, has celebrated a key milestone in the construction of the NHS’ Blood and Transplant’s new Clinical biotechnology Centre (CBC) in Filton, Bristol, with the team breaking through the new building through to the existing main building.

Works started earlier this year to deliver a new state-of-the-art building that will eventually co-locate with the Cell Therapy Facility at the Filton Blood Centre.

The two-storey extension will be 940m2 and will provide first-class facilities to support the research and development of gene therapy. The extension will include a laboratories and clean rooms as well as offices for clinical staff.

The new Clinical biotechnology Centre is set to open in 2022 and throughout construction, Kier is working with its specialist supply chain partners to deliver this centre.

David Snell, operations director for Kier Regional Building Western & Wales, states: “This is an important milestone for the new Clinical biotechnology Centre, breaking through the building means we are one step closer to linking this new extension to the main building and the centre being ready for occupation.”

Carol Ash, Accountable Executive for the Filton-CBC project, said: “We are delighted with the progress that is being made on site and we are grateful to Kier and Enbloc for their efforts in keeping this project on schedule.”

Kier is currently on site delivering vital new healthcare facilities across the UK, with other projects including the £98m transformation project at Heatherwood Hospital in Ascot.

Related content: